End-of-day quote
Shanghai S.E.
18:00:00 2024-05-09 EDT
|
5-day change
|
1st Jan Change
|
11.51
CNY
|
-1.54%
|
|
+10.35%
|
-14.55%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
6,652
|
4,255
|
3,744
|
5,961
|
6,899
|
5,605
|
Enterprise Value (EV)
1 |
4,905
|
3,430
|
3,888
|
6,902
|
7,703
|
5,989
|
P/E ratio
|
6.71
x
|
92.8
x
|
101
x
|
26.7
x
|
16.3
x
|
29.3
x
|
Yield
|
1.24%
|
0.17%
|
0.17%
|
0.42%
|
1.83%
|
1.02%
|
Capitalization / Revenue
|
1.5
x
|
2.02
x
|
2.26
x
|
2.5
x
|
1.4
x
|
1.15
x
|
EV / Revenue
|
1.11
x
|
1.63
x
|
2.35
x
|
2.89
x
|
1.57
x
|
1.23
x
|
EV / EBITDA
|
2.73
x
|
15.7
x
|
22.8
x
|
14.4
x
|
8.23
x
|
8.25
x
|
EV / FCF
|
4.08
x
|
-11.9
x
|
-7.66
x
|
-5.06
x
|
54.3
x
|
9.25
x
|
FCF Yield
|
24.5%
|
-8.43%
|
-13.1%
|
-19.8%
|
1.84%
|
10.8%
|
Price to Book
|
1.85
x
|
1.2
x
|
1.05
x
|
1.57
x
|
1.75
x
|
1.4
x
|
Nbr of stocks (in thousands)
|
411,864
|
411,864
|
411,864
|
418,596
|
418,356
|
416,145
|
Reference price
2 |
16.15
|
10.33
|
9.090
|
14.24
|
16.49
|
13.47
|
Announcement Date
|
19-03-28
|
20-04-23
|
21-04-09
|
22-04-21
|
23-04-26
|
24-04-26
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
4,432
|
2,106
|
1,653
|
2,387
|
4,914
|
4,867
|
EBITDA
1 |
1,796
|
218.9
|
170.7
|
480
|
935.6
|
725.9
|
EBIT
1 |
1,504
|
-34.15
|
-79.96
|
200.8
|
504.3
|
229.3
|
Operating Margin
|
33.94%
|
-1.62%
|
-4.84%
|
8.41%
|
10.26%
|
4.71%
|
Earnings before Tax (EBT)
1 |
1,356
|
-6.511
|
10.62
|
216.4
|
457.6
|
199.4
|
Net income
1 |
990.9
|
45.84
|
36.94
|
220.3
|
420.1
|
190.4
|
Net margin
|
22.36%
|
2.18%
|
2.23%
|
9.23%
|
8.55%
|
3.91%
|
EPS
2 |
2.406
|
0.1113
|
0.0897
|
0.5333
|
1.012
|
0.4601
|
Free Cash Flow
1 |
1,202
|
-289.3
|
-507.8
|
-1,365
|
141.9
|
647.5
|
FCF margin
|
27.11%
|
-13.74%
|
-30.71%
|
-57.19%
|
2.89%
|
13.3%
|
FCF Conversion (EBITDA)
|
66.91%
|
-
|
-
|
-
|
15.16%
|
89.2%
|
FCF Conversion (Net income)
|
121.26%
|
-
|
-
|
-
|
33.77%
|
340.07%
|
Dividend per Share
2 |
0.2000
|
0.0180
|
0.0150
|
0.0600
|
0.3020
|
0.1380
|
Announcement Date
|
19-03-28
|
20-04-23
|
21-04-09
|
22-04-21
|
23-04-26
|
24-04-26
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
144
|
942
|
804
|
383
|
Net Cash position
1 |
1,747
|
824
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
0.8457
x
|
1.962
x
|
0.8594
x
|
0.5281
x
|
Free Cash Flow
1 |
1,202
|
-289
|
-508
|
-1,365
|
142
|
648
|
ROE (net income / shareholders' equity)
|
30.6%
|
0.66%
|
0.34%
|
4.96%
|
10.4%
|
4.52%
|
ROA (Net income/ Total Assets)
|
21%
|
-0.45%
|
-0.88%
|
1.86%
|
4.52%
|
2.13%
|
Assets
1 |
4,721
|
-10,272
|
-4,185
|
11,870
|
9,295
|
8,940
|
Book Value Per Share
2 |
8.710
|
8.600
|
8.680
|
9.040
|
9.410
|
9.610
|
Cash Flow per Share
2 |
4.310
|
3.170
|
2.650
|
1.020
|
1.000
|
0.4300
|
Capex
1 |
76.2
|
526
|
1,108
|
2,048
|
402
|
63.7
|
Capex / Sales
|
1.72%
|
24.97%
|
67%
|
85.8%
|
8.18%
|
1.31%
|
Announcement Date
|
19-03-28
|
20-04-23
|
21-04-09
|
22-04-21
|
23-04-26
|
24-04-26
|
|
1st Jan change
|
Capi.
|
---|
| -14.55% | 663M | | +5.97% | 105B | | -4.19% | 63.99B | | +51.90% | 42.95B | | +17.44% | 39.2B | | +6.62% | 33.01B | | +13.00% | 20.33B | | +15.64% | 17.29B | | +22.55% | 15.72B | | +7.34% | 14.72B |
Other Commodity Chemicals
|